Asai Yuka, Tan Jerry, Baibergenova Akerke, Barankin Benjamin, Cochrane Chris L, Humphrey Shannon, Lynde Charles W, Marcoux Danielle, Poulin Yves, Rivers Jason K, Sapijaszko Mariusz, Sibbald R Gary, Toole John, Ulmer Marcie, Zip Catherine
Division of Dermatology, Queen's University, Kingston, ON, Canada.
University of Western Ontario, Windsor, ON, Canada
J Cutan Med Surg. 2016 Sep;20(5):432-45. doi: 10.1177/1203475416650427. Epub 2016 May 17.
Rosacea is a chronic facial inflammatory dermatosis characterized by background facial erythema and flushing and may be accompanied by inflammatory papules and pustules, cutaneous fibrosis and hyperplasia known as phyma, and ocular involvement. These features can have adverse impact on quality of life, and ocular involvement can lead to visual dysfunction. The past decade has witnessed increased research into pathogenic pathways involved in rosacea and the introduction of novel treatment innovations. The objective of these guidelines is to offer evidence-based recommendations to assist Canadian health care providers in the diagnosis and management of rosacea. These guidelines were developed by an expert panel of Canadian dermatologists taking into consideration the balance of desirable and undesirable outcomes, the quality of supporting evidence, the values and preferences of patients, and the costs of treatment. The 2015 Cochrane review "Interventions in Rosacea" was used as a source of clinical trial evidence on which to base the recommendations.
酒渣鼻是一种慢性面部炎症性皮肤病，其特征为面部背景性红斑和潮红，可能伴有炎性丘疹和脓疱、称为鼻赘的皮肤纤维化和增生以及眼部受累。这些特征会对生活质量产生不利影响，而眼部受累会导致视觉功能障碍。在过去十年中，对酒渣鼻发病机制的研究有所增加，并且引入了新的治疗方法。这些指南的目的是提供基于证据的建议，以协助加拿大医疗保健提供者诊断和管理酒渣鼻。这些指南由加拿大皮肤科医生专家小组制定，考虑了预期和非预期结果的平衡、支持证据的质量、患者的价值观和偏好以及治疗成本。2015年Cochrane综述《酒渣鼻的干预措施》被用作提出建议的临床试验证据来源。
